Episode 296: ASCO GU 2024 - Novel Approaches to QoL and Belzutifan

By The Uromigos - Last Updated: January 30, 2024

Cristiane Bergerot, PhD, describes her modifications of existing quality of life models, and Tom explains the QoL data of LITESPARK-005.
Dr. Bergerot is the director of the Department of Psycho-Oncology at CETTRO Cancer Research Hospital in Brasilia, Brazil.

Post Tags:Uromigos-ASCO GUUromigos-Kidney Cancer
Advertisement
Advertisement
Advertisement